Concentrix vs ExlService
CNXC and EXLS side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CNXC and EXLS compare
ExlService is the larger company, worth 3.3 times as much as Concentrix ($6.6B against $2.0B).
ExlService grew revenue faster over the last twelve months (15.6% versus 2.6% for Concentrix).
ExlService keeps more of each dollar of sales as profit, with a net margin of 11.1% compared with −24.0% at Concentrix.
Concentrix pays a dividend yielding 4.4%; ExlService does not pay one.
ExlService scores higher on the StockData Score (17 against 9 for Concentrix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CNXC | EXLS |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $6.6B |
| Share price | $32.76 | $43.92 |
| Change, 1 year | −5.1% | 10.8% |
| Change, 5 years | −82.4% | 60.2% |
| Beta (5Y) | 1.02 | 0.94 |
| Employees | 455K | 65K |
| StockData Score | ||
| Total score | 9 | 17 (better) |
| Valuation score | 3 (better) | 2 |
| Growth score | 1 | 5 (better) |
| Performance score | 0 | 6 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | – | 26.1× |
| P/S | 0.2× (better) | 2.8× |
| P/B | 1.1× (better) | 7.1× |
| EV/EBITDA | – | 16.6× |
| P/FCF | 3.5× (better) | 24.4× |
| PEG | – | 1.19 |
| FCF yield | 28.7% (better) | 4.1% |
| Fair value | $100.88 | $42.72 |
| Margin of safety | 67.5% (better) | −2.8% |
| Growth | ||
| Revenue growth (TTM) | 2.6% | 15.6% (better) |
| Revenue growth, 5Y average | 15.8% | 16.8% (better) |
| Net income growth (TTM) | −856% | 7.9% (better) |
| EPS growth (TTM) | −921% | 14.3% (better) |
| EPS growth, 5Y average | – | 24.3% |
| Profitability | ||
| Gross margin | 34.1% | 38.4% (better) |
| Operating margin | −20.9% | 14.8% (better) |
| Net margin | −24.0% | 11.1% (better) |
| FCF margin | 5.8% | 11.6% (better) |
| Return on equity | −78.2% | 27.7% (better) |
| Return on invested capital | −22.3% | 26.4% (better) |
| Financial health | ||
| Debt / equity | 2.47 | 0.55 (better) |
| Net debt / EBITDA | – | 0.44 |
| Interest coverage | – | 17.6× |
| Current ratio | 1.23 | 2.16 (better) |
| Altman Z-score | 0.39 | 6.62 (better) |
| Piotroski F-score | 4 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 4.4% | – |
| Buyback yield | 5.0% (better) | 4.8% |
| Shareholder yield | 9.4% (better) | 4.8% |
| Ownership | ||
| Held by institutions | 112% | 103% |
| Held by insiders | 13.1% | 2.1% |
| Insider net buying, 12 months | −$133M | −$3.6M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 15.1% | 6.2% |
Go deeper
- CNXC stock overview
- CNXC income statement
- CNXC valuation and score
- EXLS stock overview
- EXLS income statement
- EXLS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.